US Patent Issued to Northeastern University on June 3 for "Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria" (Massachusetts, Rhode Island Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,752, issued on June 3, was assigned to Northeastern University (Boston).

"Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria" was invented by Run Chang (Brighton, Mass.), Keerthana Subramanian (Boston), Mian Wang (Malden, Mass.) and Thomas J. Webster (Barrington, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are peptides comprising an amphiphilic backbone and a cationic heparin-binding motif peptide. The peptides can be used in methods of antimicrobial treatment."

The patent was filed on Nov. 12, 2021, under Application No. 17/525,354.

*For further information, including image...